Abound Wealth Management Novo Cure LTD Transaction History
Abound Wealth Management
- $399 Billion
- Q3 2025
A detailed history of Abound Wealth Management transactions in Novo Cure LTD stock. As of the latest transaction made, Abound Wealth Management holds 54 shares of NVCR stock, worth $733. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54
Previous 54
-0.0%
Holding current value
$733
Previous $962,000
27.44%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
286Shares Held
77.4MCall Options Held
943KPut Options Held
155K-
Black Rock Inc. New York, NY12.1MShares$165 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$146 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.9MShares$93.8 Million9.53% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$86.7 Million0.02% of portfolio
-
State Street Corp Boston, MA2.68MShares$36.4 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.43B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...